Covid-19, Critically Ill, Endothelial Dysfunction, Thrombosis
Conditions
Brief summary
The outbreak at covid-19 is caused by the SARS-CoV-2 virus. This virus can be responsible for severe respiratory failure but also for extra-respiratory organ dysfunctions associated with severe inflammatory stress. The endothelium is an important structure of the blood vessels and is implicated in the organ failure of many patients admitted in intensive care units. It could be affected by the virus and its alteration may explain the organ dysfunction of covid-19 ICU patients as well as the thrombotic processes frequently obstructed in this infection.
Interventions
None listed
Sponsors
University Hospital, Rouen
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* all adult patients admitted in ICU for covid-19 disease within the past 24 hrs
Exclusion criteria
* bactrial co-infection at admission * expected death within the next 24 hrs * pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Association of InterCellular Adhesion Molecule-1 plasma level with 28 days mortality | 24 hours | Plasma of covid-19 patients will be tested for endothelial injuries, notably with the measurement of InterCellular Adhesion Molecule 1 level by Enzym-Linked Immunosorbent Assay. The association of these levels with 28-days mortality will be evaluated as prognosis markers. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Association of Vascular Endothelial Growth Factor A plasma level with 28 days mortality | 24 hours | Vascular Endothelial Growth Factor A plasma level will be measured in blood as a marker of endothelial injury expressed in pg/mL. its association with 28 -days mortality will be evaluated. |
| Association of soluble Vascular Endothelial Growth Factor Receptor type 1 with 28 days mortality | 24 hours | This soluble receptor is another marker of endothelial injury and will be measured in blood and expressed as pg/mL. Its association with 28-days mortality will be evaluated. |
| Association of syndecan -1 plasma level with 28 days mortality | 24 hours | syndecan -1 is a marker of degradation of glycocalyx, raised during endothelial injury. It will be measured in blood and expressed as pg/mL. Its assocation with 28-days mortality will be evaluated. |
| Association of Endothelin-1 plasma level with 28 days mortality | 24 hours | Endothelin-1 will be assessed in blood as a maker of endothelial injuries, expressed in pg/mL. its association with 28 -days mortality will be evaluated. |
| Association of von Willebrandt Factor with thrombotic events | 24 hours | This marker may be raised during endothelial injury and may explained thrombotic status of covid-19 patients. Its blood levels will be measured and expressed as international unit/dL, and correlated with ICAM-1 plasma levels |
| Association of Viscoelastic testing with thrombotic events | 24 hours | Clot Stiffness and its fibrinogen and platelet contributions (expressed in kPa) will be measured as novative approach, using Quantra (Stago Inc) device, to explore hemostasis alterations of covid-19 patients. |
| Association of D-dimers plasma levels with thrombotic events | 24 hours | D-dimers si marker of enhanced thrombotic activity. It may be increased during covid-19 disease but its correlation with endothelial injury is not known. It will be measured in blood and expressed as microgrammes/L, and then correlated with ICAM-1 plasma levels |
Countries
France
Contacts
Primary Contactemmanuel besnier, MD
Backup Contactthomas clavier, MD, PhD
Outcome results
None listed